[Code of Federal Regulations]
[Title 10, Volume 1]
[Revised as of January 1, 2001]
From the U.S. Government Printing Office via GPO Access
[CITE: 10CFR35.25]

[Page 559-560]
 
                            TITLE 10--ENERGY
 
                CHAPTER I--NUCLEAR REGULATORY COMMISSION
 
PART 35--MEDICAL USE OF BYPRODUCT MATERIAL--Table of Contents
 
             Subpart B--General Administrative Requirements
 
Sec. 35.25  Supervision.

    (a) A licensee that permits the receipt, possession, use, or 
transfer of byproduct material by an individual under the supervision of 
an authorized user as allowed by Sec. 35.11(b) of this part shall:
    (1) Instruct the supervised individual in the principles of 
radiation safety appropriate to that individual's use of byproduct 
material and in the licensee's written quality management program;
    (2) Require the supervised individual to follow the instructions of 
the supervising authorized user, follow the written radiation safety and 
quality management procedures established by the licensee, and comply 
with the regulations of this chapter and the license conditions with 
respect to the use of byproduct material; and
    (3) Periodically review the supervised individual's use of byproduct 
material and the records kept to reflect this use.
    (b) A licensee that permits the preparation of byproduct material 
for medical use by an individual under the supervision of an authorized 
nuclear pharmacist or physician who is an authorized user, as allowed by 
Sec. 35.11(c), shall:
    (1) Instruct the supervised individual in the preparation of 
byproduct material for medical use and the principles of and procedures 
for radiation safety and in the licensee's written quality management 
program, as appropriate to that individual's use of byproduct material;

[[Page 560]]

    (2) Require the supervised individual to follow the instructions 
given pursuant to paragraph (b)(1) of this section and to comply with 
the regulations of this chapter and license conditions; and
    (3) Require the supervising authorized nuclear pharmacist or 
physician who is an authorized user to periodically review the work of 
the supervised individual as it pertains to preparing byproduct material 
for medical use and the records kept to reflect that work.
    (c) A licensee that supervises an individual is responsible for the 
acts and omissions of the supervised individual.

[51 FR 36951, Oct. 16, 1991, as amended at 56 FR 34121, July 25, 1991; 
59 FR 61782, Dec. 2, 1994]